202 related articles for article (PubMed ID: 27125384)
1. The analysis of the market success of FDA approvals by probing top 100 bestselling drugs.
Polanski J; Bogocz J; Tkocz A
J Comput Aided Mol Des; 2016 May; 30(5):381-9. PubMed ID: 27125384
[TBL] [Abstract][Full Text] [Related]
2. Top 100 bestselling drugs represent an arena struggling for new FDA approvals: drug age as an efficiency indicator.
Polanski J; Bogocz J; Tkocz A
Drug Discov Today; 2015 Nov; 20(11):1300-4. PubMed ID: 26160060
[TBL] [Abstract][Full Text] [Related]
3. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA
Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
[TBL] [Abstract][Full Text] [Related]
4. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
[TBL] [Abstract][Full Text] [Related]
5. Insights into the FDA 2018 New Drug Approvals.
Bedair A; Mansour FR
Curr Drug Discov Technol; 2021; 18(2):293-306. PubMed ID: 31793428
[TBL] [Abstract][Full Text] [Related]
6. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
Ilardi EA; Vitaku E; Njardarson JT
J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
[TBL] [Abstract][Full Text] [Related]
7. Rational application of drug promiscuity in medicinal chemistry.
Mei Y; Yang B
Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
[TBL] [Abstract][Full Text] [Related]
8. Medicinal Chemists Don't Just Make Drugs - The Art of Developing Low Molecular Weight Imaging Agents in Switzerland.
Auberson YP
Chimia (Aarau); 2016 Dec; 70(12):868-873. PubMed ID: 28661359
[TBL] [Abstract][Full Text] [Related]
9. Probing the links between in vitro potency, ADMET and physicochemical parameters.
Gleeson MP; Hersey A; Montanari D; Overington J
Nat Rev Drug Discov; 2011 Mar; 10(3):197-208. PubMed ID: 21358739
[TBL] [Abstract][Full Text] [Related]
10. Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five.
Stegemann S; Moreton C; Svanbäck S; Box K; Motte G; Paudel A
Drug Discov Today; 2023 Feb; 28(2):103344. PubMed ID: 36442594
[TBL] [Abstract][Full Text] [Related]
11. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
[TBL] [Abstract][Full Text] [Related]
12. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
Bonnet P
Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
[TBL] [Abstract][Full Text] [Related]
13. Recent advancements in mechanical reduction methods: particulate systems.
Leleux J; Williams RO
Drug Dev Ind Pharm; 2014 Mar; 40(3):289-300. PubMed ID: 23988193
[TBL] [Abstract][Full Text] [Related]
14. The year's new drugs & biologics 2015 - part II:Trends and highlights that marked a complicated year.
Graul AI; Cruces E; Dulsat C; Tracy M
Drugs Today (Barc); 2016 Feb; 52(2):131-63. PubMed ID: 27092342
[TBL] [Abstract][Full Text] [Related]
15. The influence of lipophilicity in drug discovery and design.
Arnott JA; Planey SL
Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
[TBL] [Abstract][Full Text] [Related]
16. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
Meanwell NA
Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
[TBL] [Abstract][Full Text] [Related]
17. Trends in small molecule drug properties: A developability molecule assessment perspective.
Agarwal P; Huckle J; Newman J; Reid DL
Drug Discov Today; 2022 Dec; 27(12):103366. PubMed ID: 36122862
[TBL] [Abstract][Full Text] [Related]
18. The influence of drug-like concepts on decision-making in medicinal chemistry.
Leeson PD; Springthorpe B
Nat Rev Drug Discov; 2007 Nov; 6(11):881-90. PubMed ID: 17971784
[TBL] [Abstract][Full Text] [Related]
19. Tailor-made amino acid-derived pharmaceuticals approved by the FDA in 2019.
Yin Z; Hu W; Zhang W; Konno H; Moriwaki H; Izawa K; Han J; Soloshonok VA
Amino Acids; 2020 Sep; 52(9):1227-1261. PubMed ID: 32880009
[TBL] [Abstract][Full Text] [Related]
20. Do drug metabolism and pharmacokinetic departments make any contribution to drug discovery?
Smith D; Schmid E; Jones B
Clin Pharmacokinet; 2002; 41(13):1005-19. PubMed ID: 12403640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
